Regulation of Sodium Channels: SCNM1 as A Therapeutic Target (G79005)

Target Name: SCNM1

NCBI ID: G79005

Regulation of Sodium Channels: SCNM1 as A Therapeutic Target

Sodium channel modifier 1 (SCNM1), also known as transcript variant 2, is a protein that plays a crucial role in the regulation of sodium (Na+) channels, which are responsible for the flow of electrical impulses in and out of cells. SCNM1 is a key regulator of the cardiac sodium channels, which are responsible for maintaining the normal heart rhythm.

SCNM1 is expressed in most tissues and cells, including the heart, brain, and throughout the body. It is a transmembrane protein that is composed of two distinct subunits, alpha-subunit and beta-subunit. The alpha-subunit is responsible for the regulation of the open state, while the beta-subunit is responsible for the regulation of the closed state.

SCNM1 is regulated by several different factors, including temperature, pH, and the presence of certain ions, such as calcium and magnesium. It is also regulated by several different signaling pathways, including the sodium/calcium signaling pathway and the neurotransmitter signaling pathway.

SCNM1 is a drug target that has been identified as a potential therapeutic target for several different diseases, including heart failure, hypertension, and epilepsy. Studies have shown that blocking SCNM1 can improve the survival rate in animal models of these diseases.

In addition to its potential therapeutic applications, SCNM1 is also a biomarker for several different diseases, including heart failure and hypertension. The level of SCNM1 expression is often reduced in individuals with heart failure and hypertension, and this reduction is associated with poor prognosis.

Furthermore, some studies have shown that blocking SCNM1 can also improve the efficacy of certain medications, such as diuretics and beta-blockers. This suggests that SCNM1 may be a useful target for the treatment of hypertension and heart failure.

In conclusion, SCNM1 is a protein that plays a crucial role in the regulation of sodium channels and is expressed in most tissues and cells in the body. It is a potential drug target and biomarker for several different diseases, including heart failure, hypertension, and epilepsy. Further research is needed to fully understand the role of SCNM1 in these diseases and to develop effective treatments.

Protein Name: Sodium Channel Modifier 1

More Common Targets